Form 4 for AQST Aquestive Therapeutics, Inc.
Accepted 2024-12-04 00:00:00 ET · period of report 2024-12-02 · accession 0000950170-24-133320 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-12-04 | 2024-12-02 | AQST | BRATTON DOUGLAS K | 10% | G - Gift | $0.00 | -40.0K | 199.8K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-02 | G | D | 40,000 | $0.00 | 199,841 | I See Footnote | — | — | (F1) These shares of common stock of Aquestive Therapeutics, Inc. (the "Issuer") are held by family trusts and entities controlled by Douglas K. Bratton. Such shares of common stock were acquired in previously reported in-kind pro rata distributions for no consideration without a change in pecuniary interest. |